Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial
Published Online: 2014-03-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Antoine Adenis•Beata Juzyna•Carmen Llacer-Moscardo•Eric François•Gilles Créhange•Isabelle Martel-Lafay•Jean-Luc Raoul•Jean-Yves Douillard•Laurent Bedenne•Marie-Pierre Galais•Meher Ben Abdelghani•Olivier Bouché•Pierre Michel•Pierre-Luc Etienne•Sophie Gourgou-Bourgade•Thierry Conroy•Valérie Boige
